Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

FAM98B antibody (AA 1-225)

FAM98B Reactivity: Human WB Host: Rabbit Polyclonal unconjugated
Catalog No. ABIN7267122
  • Target See all FAM98B products
    FAM98B (Family with Sequence Similarity 98, Member B (FAM98B))
    Binding Specificity
    • 1
    • 1
    • 1
    • 1
    AA 1-225
    Reactivity
    • 7
    • 4
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    Human
    Host
    • 7
    Rabbit
    Clonality
    • 7
    Polyclonal
    Conjugate
    • 7
    This FAM98B antibody is un-conjugated
    Application
    • 7
    • 2
    • 1
    • 1
    • 1
    • 1
    Western Blotting (WB)
    Purpose
    FAM98B Rabbit pAb
    Cross-Reactivity
    Human, Mouse, Rat
    Characteristics
    Polyclonal Antibodies
    Purification
    Affinity purification
    Immunogen
    Recombinant fusion protein containing a sequence corresponding to amino acids 1-225 of human FAM98B (NP_775882.2).
    Isotype
    IgG
  • Application Notes
    WB,1:500 - 1:2000
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.
    Preservative
    Sodium azide
    Precaution of Use
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Storage
    -20 °C
    Storage Comment
    Store at -20°C. Avoid freeze / thaw cycles.
  • Target
    FAM98B (Family with Sequence Similarity 98, Member B (FAM98B))
    Alternative Name
    FAM98B (FAM98B Products)
    Synonyms
    2610510H03Rik antibody, RGD1564603 antibody, family with sequence similarity 98 member B antibody, family with sequence similarity 98, member B antibody, FAM98B antibody, Fam98b antibody
    Background
    Positively stimulates PRMT1-induced protein arginine dimethylated arginine methylation. Promotes colorectal cancer cell malignancy.,FAM98B
    Molecular Weight
    45kDa
    Gene ID
    283742
    UniProt
    Q52LJ0
You are here: